Healthcare & Life Sciences

Restore Medical

series-b
series-b
Stage
1
Investors

About

Restore Medical develops the ContraBand™ system, a catheter-delivered implant designed to treat heart failure with reduced ejection fraction (HFrEF) by improving left ventricular function and reducing mitral regurgitation through transcatheter pulmonary artery banding.

Explore Restore Medical's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.